SMYD3 and cancer: Pan-cancer expression analysis using GEPIA2, which integrates RNA-seq data from TCGA and GTEx, revealed that SMYD3 mRNA is widely expressed across solid tumors and notably upregulated in several malignancies, including colorectal cancer (CRC) (Figure 1A).